Ryan Alexander Jones serves as Executive at Kyverna Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Ryan Alexander Jones has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on May 28, 2024 involved exercising options for 7,146 shares valued at $5.2K.
Ryan Alexander Jones currently holds 43,950 shares of Kyverna Therapeutics, Inc. (KYTX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ryan Alexander Jones has been a net neutral trader of KYTX stock. They have purchased $0 and sold $0 worth of shares.
Ryan Alexander Jones's most recent insider trade was on May 28, 2024, when they sold 7,146 shares at $0.73 per share.
Get notified when new Form 4 filings are submitted
| 10,870 |
| $0.73 |
| Discretionary |